Cargando…
27-Hydroxycholesterol, The Estrogen Receptor Modulator, Alters DNA Methylation in Breast Cancer
27-hydroxycholesterol (27-HC) is the first known endogenous selective estrogen receptor modulator (SERM), and its elevation from normal levels is closely associated with breast cancer. A plethora of evidence suggests that aberrant epigenetic signatures in breast cancer cells can result in differenti...
Autores principales: | Vini, Ravindran, Rajavelu, Arumugam, Sreeharshan, Sreeja |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8961300/ https://www.ncbi.nlm.nih.gov/pubmed/35360070 http://dx.doi.org/10.3389/fendo.2022.783823 |
Ejemplares similares
-
27‐Hydroxycholesterol represses G9a expression via oestrogen receptor alpha in breast cancer
por: Vini, Ravindran, et al.
Publicado: (2023) -
Estrogen Receptor Beta-Mediated Modulation of Lung Cancer Cell Proliferation by 27-Hydroxycholesterol
por: Hiramitsu, Shiro, et al.
Publicado: (2018) -
SUN-016 27-Hydroxycholesterol a Selective Estrogen Receptor Modulator: Profiling 27-Hydroxycholesterol Effects on Estrogen Receptor Activity in Mice
por: Asghari, Arvand, et al.
Publicado: (2019) -
27-Hydroxycholesterol Binds GPER and Induces Progression of Estrogen Receptor-Negative Breast Cancer
por: Avena, Paola, et al.
Publicado: (2022) -
Estrogen and Estrogen Receptor Modulators: Potential Therapeutic Strategies for COVID-19 and Breast Cancer
por: Hu, Shuying, et al.
Publicado: (2022)